Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cluster Analysis Identifies Distinct Patterns of T-Cell and Humoral Immune Responses Evolution Following a Third Dose of SARS-CoV-2 Vaccine in People Living with HIV.
El Moussaoui M, Desmecht S, Lambert N, Maes N, Braghini J, Marechal N, Quintana C, Briquet K, Gofflot S, Toussaint F, Hayette MP, Vermeersch P, Lutteri L, Grégoire C, Beguin Y, Rahmouni S, Moutschen M, Desmecht D, Darcis G. El Moussaoui M, et al. Among authors: toussaint f. Viruses. 2023 Jun 26;15(7):1435. doi: 10.3390/v15071435. Viruses. 2023. PMID: 37515123 Free PMC article.
Poor Adherence to Self-Applied Topical Drug Treatment Is a Common Source of Low Lesion Clearance in Patients with Actinic Keratosis-A Cross-Sectional Study.
Koch EAT, Steeb T, Bender-Säbelkampf S, Busch D, Feustel J, Kaufmann MD, Maronna A, Meder C, Ronicke M, Toussaint F, Wellein H, Berking C, Heppt MV. Koch EAT, et al. Among authors: toussaint f. J Clin Med. 2023 Jun 1;12(11):3813. doi: 10.3390/jcm12113813. J Clin Med. 2023. PMID: 37298008 Free PMC article.
Reduced T-cell response following a third dose of SARS-CoV-2 vaccine in infection-naïve people living with HIV.
Moussaoui ME, Desmecht S, Tashkeev A, Lambert N, Maes N, Braghini J, Marechal N, Quintana C, Briquet K, Gofflot S, Toussaint F, Hayette MP, Vermeersch P, Lutteri L, Grégoire C, Beguin Y, Rahmouni S, Moutschen M, Desmecht D, Darcis G. Moussaoui ME, et al. Among authors: toussaint f. J Infect. 2022 Dec;85(6):702-769. doi: 10.1016/j.jinf.2022.09.006. Epub 2022 Sep 9. J Infect. 2022. PMID: 36096313 Free PMC article. No abstract available.
Kinetics and Persistence of the Cellular and Humoral Immune Responses to BNT162b2 mRNA Vaccine in SARS-CoV-2-Naive and -Experienced Subjects: Impact of Booster Dose and Breakthrough Infections.
Desmecht S, Tashkeev A, El Moussaoui M, Marechal N, Perée H, Tokunaga Y, Fombellida-Lopez C, Polese B, Legrand C, Wéry M, Mni M, Fouillien N, Toussaint F, Gillet L, Bureau F, Lutteri L, Hayette MP, Moutschen M, Meuris C, Vermeersch P, Desmecht D, Rahmouni S, Darcis G. Desmecht S, et al. Among authors: toussaint f. Front Immunol. 2022 May 31;13:863554. doi: 10.3389/fimmu.2022.863554. eCollection 2022. Front Immunol. 2022. PMID: 35711445 Free PMC article.
Expanding natural transformation to improve beneficial lactic acid bacteria.
Di Giacomo S, Toussaint F, Ledesma-García L, Knoops A, Vande Capelle F, Fremaux C, Horvath P, Ladrière JM, Ait-Abderrahim H, Hols P, Mignolet J. Di Giacomo S, et al. Among authors: toussaint f. FEMS Microbiol Rev. 2022 Jul 20;46(4):fuac014. doi: 10.1093/femsre/fuac014. FEMS Microbiol Rev. 2022. PMID: 35254446 Free PMC article.
Sustainable responses in metastatic melanoma patients with and without brain metastases after elective discontinuation of anti-PD1-based immunotherapy due to complete response.
Dimitriou F, Zaremba A, Allayous C, Kähler KC, Gerard CL, Festino L, Schäfer S, Toussaint F, Heinzerling L, Hassel JC, Ascierto PA, Michielin O, Hauschild A, Lebbe C, Livingstone E, Ramelyte E, Cheng PF, Dummer R, Mangana J. Dimitriou F, et al. Among authors: toussaint f. Eur J Cancer. 2021 May;149:37-48. doi: 10.1016/j.ejca.2021.02.037. Epub 2021 Apr 3. Eur J Cancer. 2021. PMID: 33823361 Free article.
34 results